Clinical trials
Phase 1/2 Disease Progression trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 4 |
| Recruiting | 3 |
| Completed | 2 |
| Unknown status | 1 |
| Suspended | 1 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| AtlasMedx, Incorporated | 1 |
| Brown University | 1 |
| Engeneic Pty Limited | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Karolinska University Hospital | 1 |
| Mario Negri Institute for Pharmacological Research | 1 |
| Peking University People's Hospital | 1 |
| University of Minnesota | 1 |
| Virginia Commonwealth University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease Progression | 13 |
| Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Colonic Neoplasms | 2 |
| Recurrence | 2 |
| Breast Neoplasms | 1 |
| Burkitt Lymphoma | 1 |
| Colorectal Neoplasms | 1 |
| Diabetic Nephropathies | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
Trials
Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.